Related references
Note: Only part of the references are listed.Longitudinal optical imaging of tumor metabolism and hemodynamics
Melissa C. Skala et al.
JOURNAL OF BIOMEDICAL OPTICS (2010)
The HIF-1-active microenvironment: An environmental target for cancer therapy
Shinae Kizaka-Kondoh et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy
H. Harada et al.
BRITISH JOURNAL OF CANCER (2009)
Significance of nitroimidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia
Shinae Kizaka-Kondoh et al.
CANCER SCIENCE (2009)
The Akt/mTOR Pathway Assures the Synthesis of HIF-1α Protein in a Glucose- and Reoxygenation-dependent Manner in Irradiated Tumors
Hiroshi Harada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization
KangAe Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Relationships between Cycling Hypoxia, HIF-1, Angiogenesis and Oxidative Stress
Mark W. Dewhirst
RADIATION RESEARCH (2009)
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
Gregg L. Semenza
SEMINARS IN CANCER BIOLOGY (2009)
Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance
Norman Chan et al.
CANCER RESEARCH (2008)
Direct regulation of TWIST by HIF-1α promotes metastasis
Muh-Hwa Yang et al.
NATURE CELL BIOLOGY (2008)
Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
Mark W. Dewhirst et al.
NATURE REVIEWS CANCER (2008)
Hypoxia, DNA repair and genetic instability
Robert G. Bristow et al.
NATURE REVIEWS CANCER (2008)
The combination of hypoxia-response enhancers and an oxygen-dependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenografts
Hiroshi Harada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Detection and characterization of tumor hypoxia using pO2 histography
Peter Vaupel et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
The potential role of intrinsic hypoxia markers as prognostic variables in cancer
Eui Jung Moon et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Hypoxia-driven selection of the metastatic phenotype
Richard Sullivan et al.
CANCER AND METASTASIS REVIEWS (2007)
Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment
Benjamin J. Moeller et al.
CANCER AND METASTASIS REVIEWS (2007)
Hypoxia: A key regulator of angiogenesis in cancer
Debbie Liao et al.
CANCER AND METASTASIS REVIEWS (2007)
Hypoxia, gene expression, and metastasis
Denise A. Chan et al.
CANCER AND METASTASIS REVIEWS (2007)
Regulation of HIF-1α stability through S-nitrosylation
Fang Li et al.
MOLECULAR CELL (2007)
Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting
Mark W. Dewhirst
CANCER RESEARCH (2007)
Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia:: Implications for anticancer therapies
Philippe Martinive et al.
CANCER RESEARCH (2006)
HIF-I and tumour radiosensitivity
B. J. Moeller et al.
BRITISH JOURNAL OF CANCER (2006)
Reduced expression of hypoxia-inducible factor-1α in perinecrotic regions of solid tumors
S Sobhanifar et al.
CANCER RESEARCH (2005)
Real-time imaging of hypoxia-inducible factor-1 activity in tumor xenografts
JY Liu et al.
JOURNAL OF RADIATION RESEARCH (2005)
Cell cycle kinase inhibitor expression and hypoxia-induced cell cycle arrest in human cancer cell lines
AH Box et al.
CARCINOGENESIS (2004)
Exploiting tumour hypoxia in cancer treatment
JM Brown et al.
NATURE REVIEWS CANCER (2004)
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules
BJ Moeller et al.
CANCER CELL (2004)
YGI: A potential anticancer drug targeting hypoxia-inducible factor 1
EJ Yeo et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers
J Bussink et al.
RADIOTHERAPY AND ONCOLOGY (2003)
Tumor hypoxia: A target for selective cancer therapy
S Kizaka-Kondoh et al.
CANCER SCIENCE (2003)
Hypoxia-inducible factor-1α (HIF-1α) escapes O2-driven proteasomal degradation irrespective of its subcellular localization:: nucleus or cytoplasm
E Berra et al.
EMBO REPORTS (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
Hypoxia inhibits G1/S transition through regulation of p27 expression
LB Gardner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)